Its purchases alarm some right-wing conspiracy theorists, but in fact its ammo buying has been declining for years
Eviction notices rain down on Woodland Park in East Palo Alto
Half-measures won’t help regional lenders weather the next crisis
The camera maker’s Small World in Motion competition highlights how microscopes can enhance science’s understanding of what lies beyond the capacity of the naked eye
The sports apparel company’s new SpeedForm Apollo running shoes were featured in the recent Captain America sequel
Cornell's Johnson Graduate School of Management revamps its curriculum to give students more time for interview prep
Michael Rea, founder of Rx Savings Solutions, says he can pare employers' spending on prescription medications for workers
King of Prussia, Pa.
Founders: Dr. Robert Lefkowitz and Dr. Howard Rockman
VC Investment over the last four quarters: $26.1 million
Trevena, founded in January 2008, is a drug discovery company developing pharmaceuticals that target what are known as G-protein coupled receptors. Such drugs make up more than 40% of marketed drugs today, according to Trevena. The company's drug discovery platform is based on research from Duke University Medical Center, including that of founder and National Medal of Science winner Robert Lefkowitz.
Key to startup success: "We've been able to generate the strong investor support for this idea [because] the technology and the opportunity here is very, very unique, and the possibility of unlocking new areas of biology is so significantly different from what's currently out there."